Charles Theuer serves as Executive at Tracon Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Charles Theuer has executed 65 insider transactions totaling $966.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 11, 2020 involved purchasing 5,000 shares valued at $8.6K.
Charles Theuer currently holds 41,684 shares of Tracon Pharmaceuticals, Inc. (TCON), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Charles Theuer has been a net buyer of TCON stock. They have purchased $749.2K and sold $216.8K worth of shares.
Charles Theuer's most recent insider trade was on Mar 11, 2020, when they purchased 5,000 shares at $1.71 per share.
Get notified when new Form 4 filings are submitted
| $1.66 |
| Discretionary |
| Mar 10, 2020 | TCON | $18.7K | Purchase | 10,000 | $1.87 | Discretionary |
| Jan 22, 2020 | TCON | $3.5K | Payment | 929 | $3.76 | Discretionary |
| Aug 9, 2019 | TCON | $22.5K | Purchase | 50,000 | $0.45 | Discretionary |
| Jun 7, 2019 | ONCT | $0 | Award | 14,677 | $N/A | Discretionary |
| Jan 22, 2019 | TCON | $9.7K | Payment | 9,290 | $1.04 | Discretionary |
| Dec 21, 2018 | TCON | $32.3K | Purchase | 49,000 | $0.66 | Discretionary |
| Jan 22, 2018 | TCON | $27.4K | Payment | 9,290 | $2.95 | Discretionary |
| Jan 23, 2016 | TCON | $47.9K | Payment | 9,870 | $4.85 | Discretionary |
| Jan 21, 2016 | TCON | $0 | Award | 90,900 | $N/A | Discretionary |
| Sep 18, 2015 | TCON | $173.4K | Sale | 10,000 | $17.34 | Discretionary |
| Sep 18, 2015 | TCON | $7.0K | Option Exercise | 10,000 | $0.70 | Discretionary |
| Sep 10, 2015 | TCON | $42.2K | Sale | 3,516 | $12.00 | Discretionary |
| Aug 14, 2015 | TCON | $1.2K | Sale | 100 | $12.00 | Discretionary |